Jewish Contributions to Humanity #21 series #25 in in a series “We know we can’t wipe out the phenomenon of sexual abuse, but we can help our community become one where every survivor knows they are supported, and every abuser knows they will be held accountable.” Making lifesaving discoveries was in their blood. — SHANA AARONSON to tell anyone, so we went on our own to a pharmacy to buy a preg- nancy test. “Our biggest fear at the time was that some- one would notice young religious girls buying a pregnancy test and we would get in trouble. I understood even then that something was very, very wrong with that scenario.” She became aware of similar situa- tions in the community. “I knew that there was an issue of sexual abuse of Orthodox kids, even though I didn’t have the language or full grasp of it yet,” she said. Aaronson earned a degree in psychology from the University of Phoenix. She has worked for Tzofiah, a boarding school for adolescent girls who experienced childhood trauma, and Magen Child Protective Services. Both are run by Orthodox Jews and serve primarily Orthodox children and youth. In 2015, Aaronson was recruited to Jewish Community Watch (JCW), whose mission is to protect children from sexual abuse, educate the com- munity, and advocate for and support victims. JCW’s founder, Meyer Seewald of Brooklyn, started JWC in 2011 after learning that the father of his best friend, who had killed himself five years earlier, was molesting boys in a youth group he had started in memo- ry of his son. Seewald set up a website to expose the abuser and soon started receiving reports of similar situations from Jewish communities around the world. JCW’s website prominently features a “Wall of Shame” identifying more than 150 men accused (and often con- victed) of sexual abuse. One of them is Matthew Kuppe of West Bloomfield, a former Jewish Community Center Day Camps counselor who was sentenced last year to a 10-year prison term for filming young boys in a locker room and posting their nude photos on a Russian website. JCW recruited Aaronson in 2015 as services coordinator for Israel. She was promoted to COO a year ago. She has many administra- tive duties but likes to spend as much time as she can speaking to survivors, interviewing people involved in cases, working with the police and going to court on victims’ behalf. A “CULTURE SHIFT” Aaronson said there was a lot of resistance to JCW within the ultra- Orthodox community at first but feels a “culture shift” on the prob- lem of child sexual abuse is gaining momentum. “Today there are still many that oppose a lot of what we do, and still believe that sexual abuse is a problem that should be dealt with ‘internally’ and ‘quietly,’” she said. “Thankfully, that’s becoming more of a minority view as people are increasingly understanding the ter- rible damage that child sexual abuse causes.” JCW now has offices in Miami, Brooklyn and Israel, and is looking to expand into Europe. “We know we can’t wipe out the phenomenon of sexual abuse, but we can help our community become one where survivors know they are sup- ported, and abusers know they will be held accountable,” Aaronson said. “Our goal is to provide every support possible to every survivor who needs it, in every Jewish community all over the world.” She has enjoyed the response to her inclusion on the list of “extraor- dinary” woman of Israel. “It’s been an honor to connect with some of the other women on the list who are doing really incredible work in Israel,” she said. • To learn more about Jewish Community Watch, go to jewishcommunitywatch.org. Materials there include videos and other edu- cational material. PAUL EHRLICH (1845-1915). b. Silesia. d. Bad Homburg, Hesse, Germany. Nobel Prize in Physiology or Medicine 1908. The ‘magic bullet.’ Working in the lab of his cousin—pathologist Carl Wei- gert—Paul Ehrlich discovered that certain dyes react differ- ently with different cells and tissues, and that dyes could help scientists identify and distinguish different cells under a mi- croscope with the use of a certain dye. With physiologist Emil Behring, Ehrlich developed an antiserum (a drug that triggers an immune response to a disease) for treating diphtheria, and created the first standard- ized protocol for the production of antiserums. In 1908, Ehrlich shared a Nobel Prize with Elie Metchnikoff for their work on immunology, which included Ehrlich’s breakthroughs with antiserums and his “side chain theory,” which created a theoretical explanation for how the body creates immunity to toxins. As part of this theory, Ehrlich coined the term “magic bullet,” which refers to an immunological compound that can target a specific toxin without significantly harming surrounding cells and tissues. In 1907 Ehrlich created compound 606, also known as Salvarsan, which was the primary worldwide treatment for syphilis until peni- cillin’s advent in the 1940s. Salvarsan was very much part of Ehrlich’s quest for “magic bul- let” drugs that would crush the disease without crippling its host. It was this specific quest that is now credited with launching the field of chemotherapy. KARL LANDSTEINER (1868-1943). b. Vienna, Austria. d. New York City. Nobel Prize in Physiology or Medicine 1930. First polio, and then blood types. As a pathologist in Vienna, Karl Landsteiner, along with phy- sician Erwin Popper, isolated the polio virus, a groundbreaking discovery that eventually culminated in Jonas Salk’s discovery of a vaccine for the disease. Remarkably, though, it wasn’t this for which Landsteiner received his Nobel Prize, but his discovery of the four different blood types (A, B, AB and O) that Landsteiner had his most lasting impact on medicine. As the “father of trans- fusion medicine,” it was Landsteiner who discovered that, due to different immunological responses of antibodies, people with type AB blood are universal recipients and people with type O blood are universal donors. In effect, Landsteiner turned blood transfusions—a regular and crucial occurrence in hospitals—into a safe and predictable treatment. SELMAN WAKSMAN (1888-1973). b. Priluki, Russia. d, Falmouth, Massachusetts. Nobel Prize in Physiology or Medicine 1952. A father of antibiotics. As a biochemist at Rutgers University, Selman Waksman and his team coined the term “antibiotic” and proceeded to create many lifesaving ones, most notably streptomycin, which was the first effective treatment for tuberculosis and is consid- ered to be among a handful of basic medicines considered necessary in any society. He won the Nobel Prize for discov- ering streptomycin in 1952. A year earlier Waksman used his royalties from patents to create the Foundation for Microbiology, which funds microbiology research. Using funds from that foundation, Waksman also created the Institute of Microbi- ology at Rutgers, now called the Waksman Institute of Microbiology. Original Research by Walter L. Field Sponsored by Irwin S. Field Written by Jared Sichel jn May 31 • 2018 17